Sweden


Ozempic maker suffers ‘meltdown’ as board directors quit

Ozempic maker suffers ‘meltdown’ as board directors quit

Boardroom drama has erupted at Novo Nordisk as its market value plunges and it faces stiff competition in the weight-loss injection sector

Read now